Chicago Capital LLC 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-23 12:49 pm Purchase | 2022-12-31 | 13G | ALBIREO PHARMA INC ALBO | Chicago Capital LLC | 1,362,484 6.600% | 390,599 (+40.19%) | Filing |
| 2022-03-07 08:56 am Purchase | 2022-03-01 | 13G | ALBIREO PHARMA INC ALBO | Chicago Capital LLC | 971,885 5.100% | 971,885 (New Position) | Filing |